Home Tags VENTANA FOLR1 assay

Tag: VENTANA FOLR1 assay

Paving the Way: Mirvetuximab Soravtansine + Pembrolizumab in Endometrial Cancer

At the recently held annual meeting of the American Association for Cancer Research (AACR), positive Phase 2 trial (NCT03835819) results of the combination of mirvetuximab soravtansine and the immune checkpoint inhibitor (ICI) Pembrolizumab (Keytruda®; Merck & Co) in the treatment of folate receptor-alpha (FR-α) positive recurrent microsatellite stable / mismatch repair proficient serous endometrial cancer were presented.